Orrico, Mario
Nozzolillo, Agostino
Gelibter, Stefano
Sangalli, Francesca
Preziosa, Paolo
Filippi, Massimo http://orcid.org/0000-0002-5485-0479
Moiola, Lucia
Article History
Received: 3 March 2021
Revised: 6 April 2021
Accepted: 9 April 2021
First Online: 14 April 2021
Declarations
:
: M. Orrico, S. Gelibter and A. Nozzolillo have no conflicts of interest to report. F. Sangalli has received speaker’s honoraria and travel support form Biogen, Merck, Novartis, Roche, Sanofi-Genzyme, and TEVA. P. Preziosa received speaker honoraria from Biogen Idec, Novartis, Merck Serono and ExceMED. L. Moiola has received speaker’s honoraria from the following companies: Biogen, Merck, Novartis, Roche, Sanofi-Genzyme, and TEVA. M. Filippi is Editor-in-Chief of the <i>Journal of Neurology</i> and Associate Editor of <i>Human Brain Mapping</i>; received compensation for consulting services and/or speaking activities from Almiral, Alexion, Bayer, Biogen, Celgene, Eli Lilly, Genzyme, Merck-Serono, Novartis, Roche, Sanofi, Takeda, and Teva Pharmaceutical Industries; and receives research support from Biogen Idec, Merck-Serono, Novartis, Roche, Teva Pharmaceutical Industries, Italian Ministry of Health, Fondazione Italiana Sclerosi Multipla, and ARiSLA (Fondazione Itali- ana di Ricerca per la SLA).
Free to read: This content has been made available to all.